AC Immune SA (ACIU) Balance Sheet

NASDAQ: ACIUAssets, liabilities, debt and equity over 10 years.

ACIU balance sheet, 2025

December 31, 2025 · Swiss francs

CHF 154.4M assets = CHF 109.5M liabilities + CHF 44.9M equity

What it ownsCHF 154.4MCash & ST investments: CHF 91.4M (59.2%)Cash & ST investmentsCHF 91.4M · 59%Receivables: CHF 1.3M (0.9%)Other current: CHF 4.1M (2.6%)PP&E: CHF 6.5M (4.2%)Goodwill & intangibles: CHF 50.5M (32.7%)Goodwill & intangiblesCHF 50.5M · 33%LT investments: CHF 584,000 (0.4%)Other non-current: CHF 665 (0.0%)=How it is financedCHF 154.4MCurrent liabilities: CHF 94.8M (61.4%)Current liabilitiesCHF 94.8M · 61%Other LT liabilities: CHF 14.7M (9.5%)CHF 14.7MShareholders’ equity: CHF 44.9M (29.1%)Shareholders’ equityCHF 44.9M · 29%

Both columns are drawn to the same scale: what ACIU owns equals what it owes plus shareholders’ equity. Hover a block for its value.

ACIU financial health

Current ratio1.02
Adequate · current assets cover current liabilities 1.02×
Debt / equity0.10
Low leverage · CHF 0.10 of debt for each $1 of equity
Equity / assets29.1%
Balanced · of assets funded by shareholders
Cash / debt2,010.8%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles32.7%
Acquisition-heavy · of total assets

Descriptive bands, not a rating. Fiscal 2025.

ACIU balance sheet trends, 2016–2025

AC Immune SA balance sheet trends
MetricTrendThenLatestChange
Total assetsCHF 156.1M2016CHF 154.4M2025−0.1%/yr
Total liabilitiesCHF 13.7M2016CHF 109.5M2025+26.0%/yr
Shareholders’ equityCHF 142.4M2016CHF 44.9M2025−12.0%/yr
Cash & short-term investmentsCHF 152.2M2016CHF 91.4M2025−5.5%/yr
Total debtCHF 02016CHF 4.5M2025—
Net cash (debt)CHF 152.2M2016CHF 86.9M2025CHF 65.3M
Working capitalCHF 145.0M2016CHF 2.0M2025CHF 142.9M
Current ratio15.6120161.022025−14.59
Debt / equity0.0020160.102025+0.10
Shares outstanding50.1M2016100.8M2025+8.1%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

ACIU assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

ACIU liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

ACIU debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

ACIU balance sheet in Swiss francs

AC Immune SA annual balance sheet
2025202420232022202120202019201820172016
Assets
Cash & short-term investmentsCHF 91.4MCHF 165.5MCHF 103.0MCHF 122.6MCHF 198.2MCHF 225.9MCHF 288.6MCHF 186.5MCHF 124.4MCHF 152.2M
Cash & equivalentsCHF 26.8MCHF 36.3MCHF 78.5MCHF 31.6MCHF 82.2MCHF 160.9MCHF 193.6MCHF 156.5MCHF 124.4MCHF 152.2M
Short-term investmentsCHF 64.7MCHF 129.2MCHF 24.6MCHF 91.0MCHF 116.0MCHF 65.0MCHF 95.0MCHF 30.0MCHF 0CHF 0
ReceivablesCHF 1.3MCHF 1.1MCHF 15.0MCHF 408,000CHF 975,000CHF 1.6MCHF 1.4MCHF 4.1MCHF 3.7MCHF 1.4M
InventoryCHF 0CHF 0−CHF 622,000CHF 1−CHF 1.4M−CHF 1.9M−CHF 1.4MCHF 0−CHF 1.4MCHF 389,000
Other current assetsCHF 4.1MCHF 5.4MCHF 7.7MCHF 5.1MCHF 4.8MCHF 6.2MCHF 4.2MCHF 2.4MCHF 2.8MCHF 889,000
Total current assetsCHF 96.8MCHF 172.0MCHF 125.2MCHF 128.1MCHF 202.6MCHF 231.8MCHF 292.8MCHF 192.9MCHF 129.5MCHF 154.9M
Property, plant & equipment (net)CHF 6.5MCHF 8.1MCHF 6.9MCHF 7.1MCHF 8.0MCHF 6.6MCHF 6.2MCHF 3.3MCHF 2.4MCHF 1.1M
Goodwill & intangible assetsCHF 50.5MCHF 50.4MCHF 50.4MCHF 50.4MCHF 50.4MCHF 0CHF 0CHF 0CHF 0CHF 0
Long-term investmentsCHF 584,000CHF 415,000CHF 361,000CHF 361,000CHF 363,000CHF 334,000CHF 304,000CHF 304,000CHF 126,000CHF 86,000
Other non-current assetsCHF 665CHF 1CHF 0CHF 0CHF 0CHF 0CHF 0CHF 0CHF 0CHF 0
Total assetsCHF 154.4MCHF 230.9MCHF 182.8MCHF 185.9MCHF 261.4MCHF 238.7MCHF 299.2MCHF 196.6MCHF 132.0MCHF 156.1M
Liabilities
Accounts payableCHF 2.1MCHF 2.7MCHF 1.7MCHF 929,000CHF 2.0MCHF 2.2MCHF 142,000CHF 2.0MCHF 1.1MCHF 4.0M
Short-term debtCHF 852,000CHF 1.0MCHF 672,000CHF 548,000CHF 570,000CHF 443,000CHF 1.1MCHF 332,000CHF 0CHF 0
Deferred revenueCHF 83.7MCHF 85.1MCHF 138,000CHF 587,000CHF 717,000CHF 306,000CHF 4.5MCHF 351,000CHF 355,000CHF 521,000
Total current liabilitiesCHF 94.8MCHF 100.8MCHF 13.6MCHF 11.5MCHF 20.0MCHF 14.0MCHF 17.5MCHF 13.1MCHF 9.8MCHF 9.9M
Long-term debtCHF 0CHF 0CHF 0CHF 0CHF 0CHF 0CHF 1.8MCHF 219,838CHF 498,380CHF 0
Lease obligationsCHF 4.5MCHF 5.4MCHF 3.5MCHF 2.8MCHF 2.9MCHF 2.2MCHF 2.3MCHF 0CHF 395,000CHF 0
Other long-term liabilitiesCHF 14.7MCHF 17.8MCHF 8.6MCHF 5.5MCHF 9.4MCHF 9.2MCHF 7.5MCHF 5.6MCHF 4.9MCHF 3.8M
Total liabilitiesCHF 109.5MCHF 118.6MCHF 22.2MCHF 16.9MCHF 29.5MCHF 23.3MCHF 26.8MCHF 18.9MCHF 15.2MCHF 13.7M
Shareholders' equity
Common stock & paid-in capitalCHF 2.3MCHF 2.2MCHF 2.1MCHF 1.8MCHF 1.8MCHF 1.5MCHF 1.4MCHF 1.4MCHF 1.1MCHF 1.1M
Retained earnings (deficit)−CHF 439.5M−CHF 368.2M−CHF 316.2M−CHF 264.0M−CHF 200.9M−CHF 132.8M−CHF 75.5M−CHF 121.9M−CHF 72.6M−CHF 46.9M
Treasury stock——————CHF 0CHF 0CHF 0CHF 0
Accumulated other comprehensive incomeCHF 7,007−CHF 5,000−CHF 51,000CHF 10,000CHF 0CHF 0CHF 0−CHF 3.5MCHF 179.4M−CHF 2.2M
Minority interest——————CHF 0CHF 0CHF 0CHF 0
Total shareholders' equityCHF 44.9MCHF 112.3MCHF 160.6MCHF 169.0MCHF 232.0MCHF 215.5MCHF 272.4MCHF 177.6MCHF 116.8MCHF 142.4M
Key figures
Total debtCHF 4.5MCHF 5.4MCHF 3.5MCHF 2.8MCHF 2.9MCHF 2.2MCHF 2.9MCHF 551,838CHF 498,380CHF 0
Net cash (debt)CHF 86.9MCHF 160.1MCHF 99.6MCHF 119.8MCHF 195.3MCHF 223.7MCHF 285.7MCHF 185.9MCHF 123.9MCHF 152.2M
Working capitalCHF 2.0MCHF 71.2MCHF 111.6MCHF 116.6MCHF 182.6MCHF 217.7MCHF 275.3MCHF 179.8MCHF 119.8MCHF 145.0M
Tangible book value−CHF 5.5MCHF 61.9MCHF 110.2MCHF 118.6MCHF 181.6MCHF 215.5MCHF 272.4MCHF 177.6MCHF 116.8MCHF 142.4M
Shares outstanding100.8M99.7M84.7M83.6M75.0M71.9M71.1M61.8M57.4M50.1M
Current ratio1.021.719.2211.1610.1216.5316.7214.7513.2815.61
Quick ratio0.981.658.7010.719.9516.2316.5614.5713.1315.48
Debt / equity0.100.050.020.020.010.010.010.000.000.00
Equity / assets29.1%48.6%87.9%90.9%88.7%90.3%91.0%90.4%88.5%91.2%

Quarterly columns are labeled by the month the quarter ended. Figures in Swiss francs as reported (latest annual report filed March 13, 2026); data from EODHD.

ACIU financial position

At the end of fiscal 2025 (December 31, 2025), AC Immune had total assets of CHF 154.4 million (down 33.1% from a year earlier), total liabilities of CHF 109.5 million and shareholders' equity of CHF 44.9 million. It held CHF 91.4 million in cash and short-term investments against CHF 4.5 million of debt, a net cash position of CHF 86.9 million. Its current ratio was 1.02. In the latest quarter (ended June 30, 2026) total assets were CHF 150.4 million and equity CHF 35.2 million.

Related: ACIU income statement, ACIU cash flow statement, ACIU key metrics. See the ACIU stock overview for the latest quote and news.

ACIU balance sheet FAQ

What are AC Immune's total assets?

AC Immune reported total assets of CHF 154.4 million at the end of fiscal 2025 (December 31, 2025), compared with CHF 230.9 million a year earlier.

How much debt does AC Immune have?

AC Immune had CHF 4.5 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.10.

How much cash does AC Immune have?

AC Immune held CHF 91.4 million in cash and short-term investments at the end of fiscal 2025; with CHF 4.5 million of debt that is net cash of CHF 86.9 million.

What is AC Immune's book value?

AC Immune's shareholders' equity (book value) was CHF 44.9 million at the end of fiscal 2025.

What is AC Immune's current ratio?

AC Immune had current assets of CHF 96.8 million and current liabilities of CHF 94.8 million, a current ratio of 1.02 (it can cover its short-term obligations).

How much goodwill does AC Immune have?

AC Immune carried CHF 50.5 million of goodwill and intangible assets, 32.7% of total assets, at the end of fiscal 2025.

Biotechnology: balance sheet